Nieuws over diabetes en aanverwante onderwerpen; R'd Zuid; 15+ jr ervaring diabetesbehandeling; zus met T1D
- Tweets348
- Following368
- Followers629
- Likes11
ALT Illustration showing adults with type 2 diabetes benefit from automated insulin delivery irrespective of c-peptide level.
ALT A hundred years after the discovery of insulin, type 1 diabetes remains a chronic disease that requires lifelong daily management. This includes monitoring food intake, measuring blood glucose via finger pricks, and administering insulin shots through needles or, more recently, insulin pumps and continuous-loop devices. Improving treatment with cell therapies and delaying symptom onset with prevention strategies should enhance the future management of the disease.
ALT In a world-first medical breakthrough, scientists have successfully used a woman’s own stem cells to reverse her Type 1 diabetes, offering hope for millions living with this chronic condition. The treatment regenerates insulin-producing cells in the pancreas, restoring the body’s ability to regulate blood sugar naturally without lifelong insulin injections. This milestone highlights the incredible potential of stem cell therapy in treating autoimmune diseases. By using the patient’s own cells, researchers reduce the risk of rejection and complications, making the therapy safer and more effective. While still in the early stages, this achievement marks a turning point in diabetes research and could pave the way for accessible, life-changing treatments in the near future. It’s a powerful reminder that medical science continues to push the boundaries of what’s possible, transforming hope into reality for patients worldwide.
ALT The prediction of an individual's risk is important to know for designing and joining clinical trials and for consideration of the use of current FDA-approved therapeutics. DPTRS=Diabetes Prevention Trial-Type 1 Risk Score. GRS=genetic risk score. IA2A=insulinoma-associated protein 2 autoantibodies.
